Why Switch? - Motivations for Self-Substitution of Illegal Drugs

References

• Alford, D. P., Compton, P., & Samet, J. H. (2006). Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Annals of Internal Medicine, 144(2), 127–134. https://doi.org/10.7326/0003-4819-144-2-200601170-00010
   PubMed Web of Science ®Google Scholar
• Baggio, S., Deline, S., Studer, J., N’Goran, A., Mohler-Kuo, M., Daeppen, J.-B., & Gmel, G. (2014). Concurrent versus simultaneous use of alcohol and non-medical use of prescription drugs: is simultaneous use worse for mental, social, and health issues? Journal of Psychoactive Drugs, 46(4), 334–339. https://doi.org/10.1080/02791072.2014.921747
   PubMed Web of Science ®Google Scholar
• Baggio, S., Studer, J., Mohler-Kuo, M., Daeppen, J.-B., & Gmel, G. (2014). Concurrent and simultaneous polydrug use among young Swiss males: Use patterns and associations of number of substances used with health issues. International Journal of Adolescent Medicine and Health, 26(2), 217–224. https://doi.org/10.1515/ijamh-2013-0305
   PubMedGoogle Scholar
• Bassir Nia, A., Medrano, B., Perkel, C., Galynker, I., & Hurd, Y. L. (2016). Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis. Journal of Psychopharmacology (Oxford, England), 30(12), 1321–1330. https://doi.org/10.1177/0269881116658990
   PubMed Web of Science ®Google Scholar
• Bonar, E. E., Ashrafioun, L., & Ilgen, M. A. (2014). Synthetic cannabinoid use among patients in residential substance use disorder treatment: prevalence, motives, and correlates. Drug and Alcohol Dependence, 143, 268–271. https://doi.org/10.1016/j.drugalcdep.2014.07.009
   PubMed Web of Science ®Google Scholar
• Bonomo, Y., Norman, A., Biondo, S., Bruno, R., Daglish, M., Dawe, S., Egerton-Warburton, D., Karro, J., Kim, C., Lenton, S., Lubman, D. I., Pastor, A., Rundle, J., Ryan, J., Gordon, P., Sharry, P., Nutt, D., & Castle, D. (2019). The Australian drug harms ranking study. Journal of Psychopharmacology (Oxford, England), 33(7), 759–768. https://doi.org/10.1177/0269881119841569
   PubMed Web of Science ®Google Scholar
• Bonny-Noach, H. (2019). Harm reduction drug policy in Israel: What has been accomplished and what still needs to be done? Israel Journal of Health Policy Research, 8(1), 75. https://doi.org/10.1186/s13584-019-0343-3
   Google Scholar
• Boyd, S. J., Fang, L. J., Medoff, D. R., Dixon, L. B., & Gorelick, D. A. (2012). Use of a ‘microecological technique’ to study crime incidents around methadone maintenance treatment centers. Addiction, 107(9), 1632–1638. https://doi.org/10.1111/j.1360-0443.2012.03872.x
   PubMed Web of Science ®Google Scholar
• Boys, A., Marsden, J., Fountain, J., Griffiths, P., Stillwell, G., & Strang, J. (1999). What influences young people’s use of drugs? A qualitative study of decision-making. Drugs: Education, Prevention and Policy, 6(3), 373–387. https://doi.org/10.1080/09687639997052
   Web of Science ®Google Scholar
• Brandt, S. D., King, L. A., & Evans-Brown, M. (2014). The new drug phenomenon: Editorial and perspective. Drug Testing and Analysis, 6(7-8), 587–597. https://doi.org/10.1002/dta.1686
   PubMed Web of Science ®Google Scholar
• Brennan, R., & Van Hout, M.-C. (2012). Miaow miaow: A review of the new psychoactive drug mephedrone. Drugs and Alcohol Today, 12(4), 241–253. https://doi.org/10.1108/17459261211286654
   Google Scholar
• Brown, S. A. (2015). Stigma towards Marijuana users and heroin users. Journal of Psychoactive Drugs, 47(3), 213–220. https://doi.org/10.1080/02791072.2015.1056891
   PubMed Web of Science ®Google Scholar
• Brunt, T. M., Poortman, A., Niesink, R. J., & van den Brink, W. (2011). Instability of the ecstasy market and a new kid on the block: Mephedrone. Journal of Psychopharmacology (Oxford, England), 25(11), 1543–1547. https://doi.org/10.1177/0269881110378370
   PubMed Web of Science ®Google Scholar
• Caulkins, J. P. (2001). Drug prices and Emergency Department Mentions for Cocaine and Heroin. American Journal of Public Health, 91(9), 1446–1448. https://doi.org/10.2105/ajph.91.9.1446
   PubMed Web of Science ®Google Scholar
• Caulkins, J. P., & Reuter, P. (1998). What price data tell us about drug markets. Journal of Drug Issues, 28(3), 593–612. https://doi.org/10.1177/002204269802800302
   Web of Science ®Google Scholar
• Caulkins, J. P., & Reuter, P. (2010). How drug enforcement affects drug prices. Crime and Justice, 39(1), 213–271. https://doi.org/10.1086/652386
   Google Scholar
• Cohen, K., & Weinstein, A. M. (2018). Synthetic and non-synthetic cannabinoid drugs and their adverse effects-a review from public health prospective. Frontiers in Public Health, 6, 162. https://doi.org/10.3389/fpubh.2018.00162
   PubMed Web of Science ®Google Scholar
• Compton, W. M., Jones, C. M., & Baldwin, G. T. (2016). Relationship between nonmedical prescription-opioid use and heroin use. The New England Journal of Medicine, 374(2), 154–163. https://doi.org/10.1056/NEJMra1508490
   PubMed Web of Science ®Google Scholar
• Conway, K. P., Kane, R. J., Ball, S.A., Poling, J .C., & Rounsaville, B. J. (2003). Personality, substance of choice, and polysubstance involvement among substance dependent patients. Drug and Alcohol Dependence, 71(1), 65–75. https://doi.org/10.1016/S0376-8716(03)00068-1
   PubMed Web of Science ®Google Scholar
• Davis, W. R., & Johnson, B. D. (2008). Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug and Alcohol Dependence, 92(1–3), 263–267. https://doi.org/10.1016/j.drugalcdep.2007.08.008
   Web of Science ®Google Scholar
• Degenhardt, L., Day, C., Dietze, P., Pointer, S., Conroy, E., Collins, L., & Hall, W. (2005). Effects of a sustained heroin shortage in three Australian States. Addiction (Abingdon, England), 100(7), 908–920. https://doi.org/10.1111/j.1360-0443.2005.01094.x
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Day, C., Gilmour, S., & Hall, W. (2006). The “lessons” of the Australian “heroin” shortage. Substance Abuse Treatment, Prevention, and Policy, 1(1), 11. https://doi.org/10.1186/1747-597X-1-11
   PubMedGoogle Scholar
• Duffy, P., & Mackridge, A. J. (2014). Use and diversion of illicit methadone – under what circumstances does it occur, and potential risks associated with continued use of other substances. Journal of Substance Use, 19(1/2), 48–55. https://doi.org/10.3109/14659891.2012.734539
   Web of Science ®Google Scholar
• Dvorak, R. D., & Day, A. M. (2014). Marijuana and self-regulation: Examining likelihood and intensity of use and problems. Addictive Behaviors, 39(3), 709–712.https://doi.org/10.1016/j.addbeh.2013.11.001
   Google Scholar
• Earleywine, M., & Newcomb, M. D. (1997). Concurrent versus simultaneous polydrug use: Prevalence, correlates, discriminant validity, and prospective effects on health outcomes. Experimental and Clinical Psychopharmacology, 5(4), 353–364. https://doi.org/10.1037//1064-1297.5.4.353
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. (2017). EuropeanDrug Report 2017: Trends and Developments. Publications Office of the European Union. http://www.emcdda.europa.eu/publications/edr/trends-developments/2017
   Google Scholar
• Ferrari, J. R., Stevens, E. B., & Jason, L. A. (2009). The relationship of self-control and abstinence maintenance: An exploratory analysis of self-regulation. Journal of Groups in Addiction & Recovery, 4(1/2), 32–41. https://doi.org/10.1080/15560350802712371
   PubMedGoogle Scholar
• Fomin, D., Baranauskaite, V., Usaviciene, E., Sumkovskaja, A., Laima, S., Jasulaitis, A., Minkuviene, Z. N., Chmieliauskas, S., & Stasiuniene, J. (2018). Human deaths from drug overdoses with carfentanyl involvement—new rising problem in forensic medicine. Medicine, 97(48), e13449. (Baltimore), https://doi.org/10.1097/MD.0000000000013449
   PubMed Web of Science ®Google Scholar
• Frank, D. (2018). “I was not sick and I didn’t need to recover”: Methadone maintenance treatment (MMT) as a refuge from criminalization. Substance Use & Misuse, 53(2), 311–322. https://doi.org/10.1080/10826084.2017.1310247
   PubMed Web of Science ®Google Scholar
• Furr-Holden, C. D. M., Milam, A. J., Nesoff, E. D., Johnson, R. M., Fakunle, D. O., Jennings, J. M., & Thorpe, R. J. (2016). Not in my back yard: A comparative analysis of crime around publicly funded drug treatment centers, liquor stores, convenience stores, and corner stores in one mid-Atlantic City. Journal of Studies on Alcohol and Drugs, 77(1), 17–24. https://doi.org/10.15288/jsad.2016.77.17
   PubMed Web of Science ®Google Scholar
• Gable, R. S. (2004). Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction (Abingdon, England), 99(6), 686–696. https://doi.org/10.1111/j.1360-0443.2004.00744.x
   PubMed Web of Science ®Google Scholar
• Griffiths, P., Mounteney, J., & Laniel, L. (2012). Understanding changes in heroin availability in Europe over time: Emerging evidence for a slide, a squeeze and a shock: Editorial. Addiction (Abingdon, England), 107(9), 1539–1540. https://doi.org/10.1111/j.1360-0443.2012.03829.x
   PubMed Web of Science ®Google Scholar
• Gunderson, E. W., Haughey, H. M., Ait-Daoud, N., Joshi, A. S., & Hart, C. L. (2014). A survey of synthetic cannabinoid consumption by current cannabis users. Substance Abuse, 35(2), 184–189. https://doi.org/10.1080/08897077.2013.846288
   PubMed Web of Science ®Google Scholar
• Hammersley, R. (2010). Dangers of banning spice and the synthetic cannabinoid agonists. Addiction (Abingdon, England), 105(2), 373–373. https://doi.org/10.1111/j.1360-0443.2009.02845.x
   PubMed Web of Science ®Google Scholar
• Healey, C., Peters, S., Kinderman, P., McCracken, C., & Morriss, R. (2009). Reasons for substance use in dual diagnosis bipolar disorder and substance use disorders: A qualitative study. Journal of Affective Disorders, 113(1/2), 118–126. https://doi.org/10.1016/j.jad.2008.05.010
   PubMed Web of Science ®Google Scholar
• Hernández-Serrano, O., Gras, M. E., & Font-Mayolas, S. (2018). Concurrent and simultaneous use of cannabis and tobacco and its relationship with academic achievement amongst university students. Behavioral Sciences, 8(3), 31. https://doi.org/10.3390/bs8030031
   Web of Science ®Google Scholar
• Kaczmarek, E. (2019). How to distinguish medicalization from over-medicalization?Medicine, Health Care, and Philosophy, 22(1), 119–128. https://doi.org/10.1007/s11019-018-9850-1
   PubMed Web of Science ®Google Scholar
• Kapitány-Fövény, M., Kertész, M., Winstock, A., Deluca, P., Corazza, O., Farkas, J., Zacher, G., Urbán, R., & Demetrovics, Z. (2013). Substitutional potential of mephedrone: An analysis of the subjective effects. Human Psychopharmacology, 28(4), 308–316. https://doi.org/10.1002/hup.2297
   PubMed Web of Science ®Google Scholar
• Karjalainen, K., Kuussaari, K., Kataja, K., Tigerstedt, C., & Hakkarainen, P. (2017). Measuring concurrent polydrug use in general populations: A critical assessment. European Addiction Research, 23(3), 163–169. https://doi.org/10.1159/000477802
   PubMed Web of Science ®Google Scholar
• Kelley, A. E., Schochet, T., & Landry, C. F. (2004). Risk taking and novelty seeking in adolescence: Introduction to Part I. Annals of the New York Academy of Sciences, 1021(1), 27–32. https://doi.org/10.1196/annals.1308.003
   PubMed Web of Science ®Google Scholar
• King, L. A. (2014). Legal controls on cannabimimetics: An international dilemma?: Legal controls on cannabimimetics: An international dilemma?Drug Testing and Analysis, 6(1/2), 80–87. https://doi.org/10.1002/dta.1510
   PubMed Web of Science ®Google Scholar
• Lau, N., Sales, P., Averill, S., Murphy, F., Sato, S.-O., & Murphy, S. (2015). A safer alternative: Cannabis substitution as harm reduction. Drug and Alcohol Review, 34(6), 654–659. https://doi.org/10.1111/dar.12275
   PubMed Web of Science ®Google Scholar
• Leri, F., Bruneau, J., & Stewart, J. (2003). Understanding polydrug use: Review of heroin and cocaine co-use. Addiction (Abingdon, England), 98(1), 7–22. https://doi.org/10.1046/j.1360-0443.2003.00236.x
   PubMed Web of Science ®Google Scholar
• Leri, F., Tremblay, A., Sorge, R. E., & Stewart, J. (2004). Methadone maintenance reduces heroin- and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 29(7), 1312–1320. https://doi.org/10.1038/sj.npp.1300435
   PubMed Web of Science ®Google Scholar
• Levitt, S., Ben-Levi, E., & Gelkopf, M. (2002). Treatment with methadone and treatment with agonists]. In M. Hovav (Ed.), Treatment and rehabilitation of victims of drug use in Israel- development, description of the situation, and issues (pp. 75–88). Cherikover: Tel-Aviv: Tcherikover.
   Google Scholar
• Levy, J. (2014). The harms of drug use: Criminalisation, misinformation and stigma. International Network of People That Use Drugs (INPUD). https://www.inpud.net/The_Harms_of_Drug_Use_JayLevy2014_INPUD_YouthRISE.pdf
   Google Scholar
• Lucas, P. (2012). Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain. Journal of Psychoactive Drugs, 44(2), 125–133. https://doi.org/10.1080/02791072.2012.684624
   PubMed Web of Science ®Google Scholar
• Lucas, P., Reiman, A., Earleywine, M., McGowan, S. K., Oleson, M., Coward, M. P., & Thomas, B. (2013). Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients. Addiction Research & Theory, 21(5), 435–442. https://doi.org/10.3109/16066359.2012.733465
   Web of Science ®Google Scholar
• Lucas, P., Walsh, Z., Crosby, K., Callaway, R., Belle-Isle, L., Kay, R., Capler, R., & Holtzman, S. (2016). Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors: Cannabis substitution. Drug and Alcohol Review, 35(3), 326–333. https://doi.org/10.1111/dar.12323
   PubMed Web of Science ®Google Scholar
• Martin, C. S., Clifford, P. R., & Clapper, R. L. (1992). Patterns and predictors of simultaneous and concurrent use of alcohol, tobacco, marijuana, and hallucinogens in first-year college students. Journal of Substance Abuse, 4(3), 319–326. https://doi.org/10.1016/0899-3289(92)90039-Z
   PubMedGoogle Scholar
• Masten, A. S. (1994). Resilience in individual development: Successful adaptation despite risk and adversity. In Wang M. C. & Gordon E. W (Eds.), Educational resilience in inner-city America: Challenges and prospects (pp. 3–25). Lawrence Erlbaum Associates, Inc.
   Google Scholar
• Measham, F., Moore, K., Newcombe, R., & Smith, Z. (2010). Tweaking, bombing, dabbing and stockpiling: The emergence of mephedrone and the perversity of prohibition. Drugs and Alcohol Today, 10(1), 14–21. https://doi.org/10.5042/daat.2010.0123
   Google Scholar
• Miron, J. A. (2003). The effect of drug prohibition on drug prices: evidence from the markets for cocaine and heroin. The Review of Economics and Statistics, 85(3), 522–530. https://doi.org/10.1162/003465303322369696
   Web of Science ®Google Scholar
• Misailidi, N., Papoutsis, I., Nikolaou, P., Dona, A., Spiliopoulou, C., & Athanaselis, S. (2018). Fentanyls continue to replace heroin in the drug arena: The cases of ocfentanil and carfentanil. Forensic Toxicology, 36(1), 12–32. https://doi.org/10.1007/s11419-017-0379-4
   PubMed Web of Science ®Google Scholar
• Mitchell, S. G., Kelly, S. M., Brown, B. S., Reisinger, H. S., Peterson, J. A., Ruhf, A., Agar, M.H., O’Grady, K.E., & Schwartz, R.P. (2009). Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. The American Journal on Addictions, 18(5), 346–355. https://doi.org/10.1080/10550490903077820
   PubMed Web of Science ®Google Scholar
• Neal, D. J., & Carey, K. B. (2007). Association between alcohol intoxication and alcohol-related problems: An event-level analysis. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors, 21(2), 194–204. https://doi.org/10.1037/0893-164X.21.2.194
   PubMed Web of Science ®Google Scholar
• Negrei, C., Galateanu, B., Stan, M., Balalau, C., Dumitru, M. L. B., Ozcagli, E., Fenga, C., Kovatsi, L., Fragou, D., & Tsatsakis, A. (2017). Worldwide legislative challenges related to psychoactive drugs. DARU Journal of Pharmaceutical Sciences, 25(1). https://doi.org/10.1186/s40199-017-0180-2
   Google Scholar
• Nolan, M. L., Allen, B., Kunins, H. V., & Paone, D. (2016). A public health approach to increased synthetic cannabinoid-related morbidity among New York City residents, 2014-2015. The International Journal on Drug Policy, 34, 101–103. https://doi.org/10.1016/j.drugpo.2016.05.014
   PubMed Web of Science ®Google Scholar
• Nutt, D. J., King, L. A., & Phillips, L. D., & et al. (2010). Drug harms in the UK: A multicriteria decision analysis. The Lancet, 376(9752), 1558–1565. https://doi.org/10.1016/S0140-6736(10)61462-6
   PubMed Web of Science ®Google Scholar
• O’Connor, L. E., Berry, J. W., Morrison, A., & Brown, S. (1995). The Drug-of-Choice phenomenon psychological differences among drug users who preferred different drugs. The International Journal of the Addictions, 30(5), 541–555. https://doi.org/10.3109/10826089509048743
   PubMed Web of Science ®Google Scholar
• O’Connor, L., & Berry, J.W. (1990). The drug-of-choice phenomenon: why addicts start using their preferred drug. Journal of Psychoactive Drugs, 22(3), 305–311. https://doi.org/10.1080/02791072.1990.10472553
   PubMed Web of Science ®Google Scholar
• Percy, A. (2008). Moderate adolescent drug use and the development of substance use self-regulation. International Journal of Behavioral Development, 32(5), 451–458. https://doi.org/10.1177/0165025408093664
   Web of Science ®Google Scholar
• Petry, N. M. (2001). A behavioral economic analysis of polydrug abuse in alcoholics: Asymmetrical substitution of alcohol and cocaine. Drug and Alcohol Dependence, 62(1), 31–39. https://doi.org/10.1016/S0376-8716(00)00157-5
   PubMed Web of Science ®Google Scholar
• Petry, N. M., & Bickel, W. K. (1998). Polydrug abuse in heroin addicts: A behavioral economic analysis. Addiction (Abingdon, England), 93(3), 321–335. https://doi.org/10.1046/j.1360-0443.1998.9333212.x
   PubMed Web of Science ®Google Scholar
• Prosser, J. M., & Nelson, L. S. (2012). The toxicology of bath salts: A review of synthetic cathinones. Journal of Medical Toxicology: Official Journal of the American College of Medical Toxicology, 8(1), 33–42. https://doi.org/10.1007/s13181-011-0193-z
   PubMedGoogle Scholar
• Reiman, A. (2009). Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal, 6(1), 35. https://doi.org/10.1186/1477-7517-6-35
   PubMed Web of Science ®Google Scholar
• Roche, A., McCabe, S., & Smyth, B. P. (2008). Illicit methadone use and abuse in young people accessing treatment for opiate dependence. European Addiction Research, 14(4), 219–225. https://doi.org/10.1159/000149631
   PubMed Web of Science ®Google Scholar
• Roisman, G. I. (2005). Conceptual clarifications in the study of resilience. The American Psychologist, 60(3), 264–265. https://doi.org/10.1037/0003-066X.60.3.264
   PubMed Web of Science ®Google Scholar
• Roy, É., Haley, N., Leclerc, P., Cédras, L., Blais, L., & Boivin, J.-F. (2003). Drug injection among street youths in Montreal: Predictors of initiation. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 80(1), 92–105. https://doi.org/10.1093/jurban/jtg092
   PubMed Web of Science ®Google Scholar
• Sason, A., Adelson, M., Schreiber, S., & Peles, E. (2018). Pregabalin misuse in methadone maintenance treatment patients in Israel: Prevalence and risk factors. Drug and Alcohol Dependence, 189, 8–11. https://doi.org/10.1016/j.drugalcdep.2018.04.025
   PubMed Web of Science ®Google Scholar
• Shalit, N., Barzilay, R., Shoval, G., Shlosberg, D., Mor, N., Zweigenhaft, N., Weizman, A., & Krivoy, A. (2016). Characteristics of synthetic cannabinoid and cannabis users admitted to a psychiatric hospital: A comparative study. The Journal of Clinical Psychiatry, 77(08), e989–995. https://doi.org/10.4088/JCP.15m09938
   PubMedGoogle Scholar
• Stenbacka, M. (1990). Initiation into intravenous drug abuse. Acta Psychiatrica Scandinavica, 81(5), 459–462. https://doi.org/10.1111/j.1600-0447.1990.tb05481.x
   PubMed Web of Science ®Google Scholar
• Stevens, A., Fortson, R., Measham, F., & Sumnall, H. (2015). Legally flawed, scientifically problematic, potentially harmful: The UK Psychoactive Substance Bill. The International Journal on Drug Policy, 26(12), 1167–1170. https://doi.org/10.1016/j.drugpo.2015.10.005
   PubMed Web of Science ®Google Scholar
• Stogner, J. M., & Miller, B. L. (2014). A spicy kind of high: A profile of synthetic cannabinoid users. Journal of Substance Use, 19(1-2), 199–205. https://doi.org/10.3109/14659891.2013.770571
   Web of Science ®Google Scholar
• Swift, W., Maher, L., & Sunjic, S. (1999). Transitions between routes of heroin administration: A study of Caucasian and Indochinese heroin users in south-western Sydney, Australia. Addiction (Abingdon, England), 94(1), 71–82. https://doi.org/10.1046/j.1360-0443.1999.941714.x
   PubMed Web of Science ®Google Scholar
• Van Hout, M. C., & Brennan, R. (2012). Curiosity killed M-Cat: A post-legislative study on mephedrone use in Ireland. Drugs: Education, Prevention and Policy, 19(2), 156–162. https://doi.org/10.3109/09687637.2011.617796
   Web of Science ®Google Scholar
• Webb, E., Ashton, C., Kelly, P., & Kamali, F. (1996). Alcohol and drug use in UK university students. The Lancet, 348(9032), 922–925. https://doi.org/10.1016/S0140-6736(96)03410-1
   PubMed Web of Science ®Google Scholar
• Wills, T. A., Vaccaro, D., & McNamara, G. (1994). Novelty seeking, risk taking, and related constructs as predictors of adolescent substance use: An application of Cloninger’s theory. Journal of Substance Abuse, 6(1), 1–20. https://doi.org/10.1016/S0899-3289(94)90039-6
   PubMedGoogle Scholar
• Winstock, A. R., & Barratt, M. J. (2013). Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and Alcohol Dependence, 131(1-2), 106–111. https://doi.org/10.1016/j.drugalcdep.2012.12.011
   PubMed Web of Science ®Google Scholar
• Wood, D. M., Measham, F., & Dargan, P. I. (2012). ‘Our favourite drug’: Prevalence of use and preference for mephedrone in the London night-time economy 1 year after control. Journal of Substance Use, 17(2), 91–97. https://doi.org/10.3109/14659891.2012.661025
   Web of Science ®Google Scholar